Cross Country Healthcare Confirms Acquisition by Knox Lane, Reports Weak Q1 Earnings, Cancels Call

summarizeSummary

Cross Country Healthcare confirmed its definitive merger agreement with Knox Lane for $13.25 per share, while simultaneously reporting weak first-quarter financial results and canceling its earnings call due to the pending acquisition.

check_boxKey Events

• Definitive Merger Agreement Confirmed

  The company confirmed it has entered into a definitive agreement to be acquired by Knox Lane for $13.25 per share in an all-cash transaction. This follows the initial announcement of the acquisition on May 6, 2026, and an earlier 8-K filing today.

• Weak Q1 2026 Financial Results Reported

  Cross Country Healthcare announced first-quarter 2026 revenue of $241.1 million, an 18% decrease year-over-year. The company reported a net loss of $4.3 million and diluted EPS of $(0.14), significantly worse than the prior year.

• Earnings Conference Call Canceled

  Due to the pending merger, the company canceled its scheduled earnings conference call to discuss first-quarter 2026 financial results, signaling the finality of the acquisition.

• Share Repurchase Activity

  During the first quarter of 2026, the company repurchased 0.7 million shares of its common stock for an aggregate price of $5.8 million, at an average market price of $8.86 per share.

auto_awesomeAnalysis

This filing confirms the definitive merger agreement for Cross Country Healthcare to be acquired by Knox Lane for $13.25 per share, reiterating the major news previously disclosed. Concurrently, the company reported weak first-quarter 2026 financial results, including significant year-over-year declines in revenue, net loss, and Adjusted EBITDA. The scheduled earnings conference call was canceled due to the pending acquisition, underscoring the imminent change in company ownership. Despite the operational challenges, the acquisition provides a premium exit for shareholders, with the offer price slightly above the current market price.